Current Business Affairs Global Point of Care (POC) Diagnostic Market 2018 | Page 2

•
•
•
•
Hematology Testing
Drugs-of-Abuse Testing
Fecal Occult Testing
Other
Some of the major end-user for the global POC diagnostics market has been segregated as:
•
•
•
•
•
Professional Diagnostic Centers
Hospitals
Home Care
Clinics
Others
Obtain report details with TOC @ https://www.xpodenceresearch.com/Reports/Point-of-Care-(POC)-Diagnostic-
Market
Home care segment is anticipated to hold at the highest rate over the forecast period
Clinics segment has been projected to hold the largest market share with respect to revenue generation owing to
substantial number of Clinical Laboratory Improvement Amendments (CLIA) -waived tests are implemented within
clinics. Furthermore, decentralization of primary care services in several regional markets around the world has become
a common trend, significantly positively impacting the future progress.
Additionally, easy-to-use POC devices availability in out-of-hospital laboratory settings has resulted in the significant
share of the segment. Furthermore, government bodies, such as National Health Service (NHS), are undertaking POCT-
based initiatives and schemes to reduce the pressures on frontline care. POCT initiatives have stimulated the primary
care settings, such as clinic, to adopt POCT services for diagnosis of various diseases. However, home care segment has
been expected to emerge as the fast-growing segment over the forecast period. Growing concern for initial detection
and elimination of any chronic condition occurrence is predicted to drive the segment growth over the forecast period.
Geographically, the global POC diagnostic market has been segregated into North America, Europe, Asia Pacific, the
Middle East and Africa and Latin America, market share¸ with revenue (Billion USD), and growth rate for these regions,
from 2015 to 2025 (forecast)
•
•
•
•
•
North America: U.S., Rest of North America
Europe: Germany, France, UK, rest of Europe
Asia Pacific: China, Japan, India and Rest of Asia Pacific
Middle East & Africa: GCC, South Africa, North Africa and Rest of MEA
Latin America: Brazil and Rest of Latin America
North America region has been expected to hold the major market share owing to the rising geriatric population base
and the presence of higher healthcare expenditure levels. Furthermore, high awareness amongst physicians and
patients coupled with early disease diagnosis support the largest share of region in the industrial revenue.
Asia Pacific region is estimated to grow with fastest CAGR over the forecast period since, the companies in the region
are engaged in capitalizing the untapped potential in the region to enhance market position. Additionally, growing
awareness for rapid disease detection to improve the patient survival rate is expected to boost the POC products.
Some of the prominent players operating in POC diagnostic market include Abbott Laboratories, bioMérieux SA, Roche
Diagnostics (A